VC + CRO

Former Scandinavia Novartis CSO targets $50M for first Vanadis Capital fund

VC + CRO

Swedish life sciences venture capital firm Vanadis Capital is raising its first fund and hopes to have a $50 million

Read the full 226 word article

How to gain access

Continue reading with a
two-week free trial.